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Abstract Regular exercise has widespread health benefits. Fundamental to these beneficial
effects is the ability of the heart to intermittently and substantially increase its performance without
incurring damage, but the underlying homeostatic mechanisms are unclear. We identify the ROS-
generating NADPH oxidase-4 (Nox4) as an essential regulator of exercise performance in mice.
Myocardial Nox4 levels increase during acute exercise and trigger activation of the transcription
factor Nrf2, with the induction of multiple endogenous antioxidants. Cardiomyocyte-specific Nox4-
deficient (csNox4KO) mice display a loss of exercise-induced Nrf2 activation, cardiac oxidative
stress and reduced exercise performance. Cardiomyocyte-specific Nrf2-deficient (csNrf2KO) mice
exhibit similar compromised exercise capacity, with mitochondrial and cardiac dysfunction.
Supplementation with an Nrf2 activator or a mitochondria-targeted antioxidant effectively restores
cardiac performance and exercise capacity in csNox4KO and csNrf2KO mice respectively. The
Nox4/Nrf2 axis therefore drives a hormetic response that is required for optimal cardiac
mitochondrial and contractile function during physiological exercise.
DOI: https://doi.org/10.7554/eLife.41044.001
Introduction
Regular physical exercise has widespread beneficial effects on multiple body systems in healthy indi-
viduals and increases quality of life and lifespan. It is one of the most effective ways of preventing
cardiovascular disease through reduction in risk factors such as obesity, hypertension and metabolic
syndrome and by enhancing vascular function (Mann and Rosenzweig, 2012). Regular exercise also
reduces morbidity and mortality in conditions such as chronic heart failure and dementia
(Sharma et al., 2015). Fundamental to these beneficial effects of exercise is the capacity of the heart
to substantially increase its performance and output during exercise, safely and without detriment to
the heart itself. The intrinsic mechanisms that underlie the physiological adaptation of the heart to
regular exercise are therefore crucial to its overall beneficial effects (Vega et al., 2017).
Previous studies show that intrinsic pathways that mediate cardiac adaptive responses to exercise
are triggered rapidly, even after just 1–3 bouts of consecutive exercise, and are sufficiently robust to
provide significant cardioprotection (Demirel et al., 2001; Powers et al., 2008). Among the candi-
date pathways involved in the adaptive response to acute exercise are those that maintain a balance
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between reactive oxygen species (ROS) and endogenous antioxidant defences. The maintenance of
a physiological redox state is crucial for all cellular functions and is likely to be especially important
when cardiac workload and the activity of metabolic pathways that support it are changing rapidly
during exercise. Myocardial ROS levels rise transiently during acute exercise (Muthusamy et al.,
2012), which is thought to be related to enhanced activity of the mitochondrial respiratory chain dur-
ing increases in cardiac contractility. Excessive levels of ROS (oxidative stress) could cause damage
to membranes, proteins and DNA and lead to detrimental consequences such as mitochondrial,
metabolic and cellular dysfunction. However, these potentially detrimental effects are limited by
endogenous antioxidant defences, and exercise has been found to increase antioxidant capacity in
the heart and skeletal muscle (Powers et al., 2014; Radak et al., 2017). Interestingly, low-level
increases in ROS may themselves induce a response that counteracts oxidative stress (termed horm-
esis), which represents a physiological adaptive mechanism (Radak et al., 2017). However, the sour-
ces of ROS that may be involved and their regulatory roles in this process remain elusive.
Figure 1. Nox4 mediates myocardial Nrf2 activation and is essential in the acute response to exercise. (A)
Changes in myocardial Nox4 mRNA and protein levels after acute moderate exercise (Ex) compared to sedentary
controls (Sed). *p<0.05, **p<0.01, 2-tailed t-test (n = 4–6/group). (B) Exercise capacity of Nox4-null mice (Nox4KO)
and littermate wild-types (WT) measured by maximal running distance and running time. **p<0.01, 2-tailed t-test
(n = 5–8/group). (C) Ratio of glutathione/glutathione disulfide (GSH/GSSG) in Nox4KO and WT mouse hearts
before (Sed) and after exercise (Ex). n = 6–9/group. (D) Protein levels of 4-hydroxynonenal (4-HNE) adducts in the
heart. n = 3–4/group. (E and F) Protein and mRNA levels of major Nrf2 targets. n = 3–6/group *p<0.05, **p<0.01
vs respective sedentary controls (Sed); #p<0.05, ##p<0.01 vs WT/Ex, 1-way ANOVA followed by Tukey post hoc
analysis. CAT: catalase, GSTA2: glutathione S-transferase A2, GCLC: glutamate cysteine ligase catalytic subunit,
TXNRD1: thioredoxin reductase 1.
DOI: https://doi.org/10.7554/eLife.41044.002
The following figure supplements are available for figure 1:
Figure supplement 1. Full images of Western blots in Figure 1.
DOI: https://doi.org/10.7554/eLife.41044.003
Figure supplement 2. Myocardial Nox2 is unchanged during acute exercise.
DOI: https://doi.org/10.7554/eLife.41044.004
Figure supplement 3. Quantification of Western blots in Figure 1E.
DOI: https://doi.org/10.7554/eLife.41044.005
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Nuclear factor E2-related factor 2 (Nrf2) is a transcription factor which is a master regulator of cel-
lular redox balance. It binds to antioxidant response elements (AREs) in the promoter regions of its
target genes which include enzymes involved in glutathione biosynthesis and maintenance such as
glutamate-cysteine ligase catalytic subunit (GCLC) and glutathione reductase; antioxidant enzymes
such as catalase (CAT), thioredoxin reductases (TRXRs) and haem oxygenase-1, and detoxification
enzymes such as NAD(P)H quinone dehydrogenase 1 (NQO1) and glutathione S-transferases (GSTs)
(Niture et al., 2014). Nrf2 normally undergoes rapid turnover through ubiquitination and proteoso-
mal degradation. However, upon exposure to oxidants or electrophiles, its associated protein Keap1
is modified and enables Nrf2 to be stabilised and then accumulate in the nucleus to mediate gene
transcription. Previous work implicates the upregulation of Nrf2 and endogenous antioxidant defen-
ces as an adaptive response to exercise in heart and skeletal muscle (Done and Traustado´ttir,
2016; Muthusamy et al., 2012; Oh et al., 2017; Wang et al., 2016).
NADPH oxidase-4 (Nox4) is a member of the Nox family proteins, which generate ROS by catalys-
ing electron transfer from NADPH to molecular O2 (Lasse`gue et al., 2012). Unlike other ROS sour-
ces such as mitochondria, uncoupled nitric oxide synthases and xanthine oxidases, the Nox enzymes
produce ROS as their primary function and have been shown to be involved in diverse redox signal-
ling pathways. In contrast to other mammalian Nox isoforms, Nox4 is constitutively active and is reg-
ulated mainly by its abundance (Zhang et al., 2013). Previous studies show that cardiac Nox4 levels
rise in response to diverse cellular stresses (Lasse`gue et al., 2012; Zhang et al., 2010), in part as a
transcriptional response to ATF4 (Santos et al., 2016). In the disease setting of chronic pressure
overload, the upregulation of Nox4 promotes adaptive cardiac remodelling through effects that
include a preservation of myocardial capillary density (Zhang et al., 2010; Zhang et al., 2018) and
Figure 2. Cardiac Nox4 deficiency impairs heart function and exercise capacity due to lack of Nrf2 activation. (A)
Expression of Nrf2-related genes in hearts of cardiomyocyte-specific Nox4KO (csNox4KO) and littermate controls
after exercise (Ex). n = 3–4/group. **p<0.01 vs respective sedentary controls (Sed); #p<0.05, ##p<0.01 vs Control/
Ex. (B) Maximal exercise distance and time. n = 3–5/group. *p<0.05 vs Control/Ex; #p<0.05, ##p<0.01 vs
csNox4KO/Ex, 1-way ANOVA followed by Tukey post hoc analysis. (C) Fractional shortening (FS) evaluated by
conscious echocardiography in control and csNox4KO mice immediately after the exercise capacity test. Some
animals were treated with sulforaphane (SFN) prior to exercise. n = 4–12/group. **p<0.01 vs Sed; ##p<0.01 vs
Control/Ex, 2-way ANOVA followed by Tukey post hoc analysis. Cat: catalase, Gsta2: glutathione S-transferase A2,
Gclc: glutamate cysteine ligase catalytic subunit, Txnrd1: thioredoxin reductase 1.
DOI: https://doi.org/10.7554/eLife.41044.006
The following figure supplement is available for figure 2:
Figure supplement 1. csNox4KO mice exhibit reduced cardiac function at peak exercise.
DOI: https://doi.org/10.7554/eLife.41044.007
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an Nrf2-dependent enhancement of myocardial redox state (Smyrnias et al., 2015). However, it is
not known whether Nox4 plays any physiological role in the heart.
Here, we report that cardiomyocyte Nox4 is an essential mediator of the physiological activation
of the Nrf2 pathway during acute exercise, triggering an adaptive response that preserves redox bal-
ance, mitochondrial function and exercise performance. Our findings identify a novel physiological
pathway that is required for the heart to safely and efficiently support physical exercise.
Results
Nox4 is required for a physiological exercise response
It was previously shown that Nox4 mRNA and protein levels are low in the adult mouse heart but are
upregulated by chronic hemodynamic overload (Zhang et al., 2010). We first analysed whether myo-
cardial Nox4 levels change in response to physiological exercise. In mice subjected to 2 bouts of
Figure 3. Cardiomyocyte-targeted Nrf2 knockout mice have impaired mitochondrial function and reduced heart
performance upon exercise. (A) Targeting strategy for generation of Nrf2fl/fl mice (Flox). The endogenous Nrf2
locus is shown at the top and the targeting vector at the bottom. Exons 2–5 were flanked by LoxP sites which are
represented by blue triangles; FRT (Neo) and F3 (Puro) sites are shown by double red triangles. Cre-mediated
recombination deletes a 5.5 kb fragment including most of the open-reading frame and the 3’UTR. (B) Southern
blot analysis of genomic DNA from selected ES cell clones, performed after excision at HincII sites, showing
correct 3’ homologous recombination in all clones. WT indicates wild-type. (C) Nrf2 mRNA levels (n = 6/group)
and (D) protein levels (n = 3/group) in the hearts of csNrf2KO and Flox control mice. **p<0.01, 2-tailed t-test. (E)
Increase in Nox4 mRNA levels in csNrf2KO and control mouse hearts after acute moderate exercise. **p<0.01 vs
respective sedentary controls, 2-tailed t-test (n = 6/group). (F) Fractional shortening (FS) by echocardiography
immediately after the exercise capacity test. *p<0.05 vs sedentary (Sed) Flox control mice, 1-way ANOVA followed
by Tukey post hoc analysis (n = 6–7/group). (G) Respiration rates in isolated cardiac mitochondria of csNrf2KO and
control mice after exercise. Both ADP-limited oxidative phosphorylation (OXPHOSLim) and maximal oxidative
capacity (OXPHOSMax) were measured (see Materials and methods for details). *p<0.05 vs csNrf2KO/Sed, #
p<0.05 Flox/Ex, 1-way ANOVA followed by Tukey post hoc analysis (n = 4–6/group). (H) Citrate synthase (CS)
activity in the heart. n = 4–6/group.
DOI: https://doi.org/10.7554/eLife.41044.008
The following figure supplements are available for figure 3:
Figure supplement 1. Identification of csNrf2KO mouse.
DOI: https://doi.org/10.7554/eLife.41044.009
Figure supplement 2. csNrf2KO mice exhibit normal cardiac morphology and function at baseline.
DOI: https://doi.org/10.7554/eLife.41044.010
Figure supplement 3. Respiratory rates in isolated cardiac mitochondria of csNrf2KO mice after exercise.
DOI: https://doi.org/10.7554/eLife.41044.011
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1500 m moderate intensity treadmill exercise on consecutive days, there was a significant increase in
myocardial Nox4 mRNA and protein levels as compared to sedentary mice (Figure 1A and Fig-
ure 1—figure supplement 1A). No change was observed in the expression levels of Nox2, the other
main Nox isoform that is expressed in the heart (Figure 1—figure supplement 2A) or in Nox2 acti-
vation as assessed by the membrane translocation of its essential regulatory subunit, p47phox, after
physiological exercise (Figure 1—figure supplement 2B). We next conducted a maximal exercise
capacity test in which Nox4-null mice and matched wild-type littermates were run to exhaustion on
day 3. This test revealed that Nox4-null mice had a maximal running distance that was ~60% of that
in wild-type controls and a maximal running time that was ~65% of that in controls (Figure 1B).
These results indicate that Nox4 has an essential role in facilitating acute exercise in healthy mice.
Nox4 mediates exercise-induced activation of Nrf2 in the heart
To investigate potential mechanisms underlying the lower exercise capacity in Nox4-null mice, we
first assessed exercise-induced changes in myocardial redox state. The ratio of glutathione/glutathi-
one disulfide (GSH/GSSG), a sensitive marker of cellular redox state, was significantly lower after
treadmill running in Nox4-null compared to sedentary mouse hearts (Figure 1C). Consistent with a
more oxidized cellular environment, the levels of 4-hydroxynonenal (4-HNE) adducts as a marker of
lipid peroxidation due to oxidative stress were significantly increased in the myocardium of Nox4-
Figure 4. Cardiomyocyte Nrf2 is required for increase in mitochondrial antioxidant capacity with exercise. (A)
Western blots for peroxiredoxin III (PRXIII), thioredoxin reductase-2 (TRXR2) and superoxide dismutase-2 (SOD2) in
heart of csNrf2KO and Flox controls after acute exercise (Ex). Mean data from n = 4–6/group are shown on the
right. *p<0.05 vs respective sedentary controls (Sed); #p<0.05, ##p<0.01 vs Flox/Ex, 1-way ANOVA followed by
Tukey post hoc analysis. (B) In vivo mitochondrial H2O2 levels assessed by the MitoP/MitoB ratio in hearts of
csNrf2KO mice and controls after acute exercise. **p<0.01 vs Flox/Sed, 1-way ANOVA followed by Tukey post hoc
analysis (n = 5–6/group). (C) MitoQ treatment improved cardiac contractile performance at peak exercise in
csNrf2KO mice. n = 6–7/group. (D) and (E) The effect of MitoQ treatment on maximal running distance and time.
n = 7–11/group. *p<0.05, **p<0.01 vs Flox/Ex, #p<0.05, ##p<0.01 vs csNrf2KO/Ex, 2-way ANOVA followed by
Tukey post hoc analysis.
DOI: https://doi.org/10.7554/eLife.41044.012
The following figure supplements are available for figure 4:
Figure supplement 1. Full images of Western blots in Figure 4.
DOI: https://doi.org/10.7554/eLife.41044.013
Figure supplement 2. Nox4 is required for increase in mitochondrial antioxidant capacity with exercise.
DOI: https://doi.org/10.7554/eLife.41044.014
Figure supplement 3. Mitochondrial-targeted antioxidant MitoQ improves cardiac response to exercise in
csNrf2KO.
DOI: https://doi.org/10.7554/eLife.41044.015
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null mice after exercise (Figure 1D and Figure 1—figure supplement 1B). These results suggest
that the loss of exercise-induced increase in Nox4 levels results in elevated oxidative stress in the
heart after acute exercise.
Since Nrf2 is an important regulator of exercise-induced redox adaptations (Done and Trausta-
do´ttir, 2016), we assessed whether the absence of Nox4 affects Nrf2 levels during acute exercise.
Myocardial Nrf2 protein levels were significantly elevated after acute exercise in wild-type mice but
this response was absent in Nox4-null mice (Figure 1E and Figure 1—figure supplement 1C and
Figure 1—figure supplement 3). In parallel with the rise in Nrf2, wild-type mouse hearts showed
increases in transcript levels of the major Nrf2 target genes Cat, Gsta2, Gclc and Txnrd1 (Figure 1F),
as well as increases at protein level (Figure 1E and Figure 1—figure supplement 1C and Figure 1—
figure supplement 3). However, there was no increase in levels of these antioxidant defence pro-
teins after exercise in Nox4-null mice (Figure 1E and Figure 1—figure supplement 1C and Fig-
ure 1—figure supplement 3). No differences were observed between wild-type and Nox4-null
mouse hearts at baseline. Therefore, physiological exercise-induced activation of the Nrf2 pathway
in the heart appears to be dependent on endogenous Nox4.
Cardiac Nox4 deficiency impairs heart function and exercise capacity
due to lack of Nrf2 activation
To exclude potential systemic effects of global Nox4 deficiency and to specifically establish the func-
tional role of cardiomyocyte Nox4 during exercise, we next studied inducible cardiomyocyte-specific
Nox4 knockout (csNox4KO) mice (Zhang et al., 2018). csNox4KO mice were compared to Cre-neg-
ative Flox control mice. Similar to Nox4-null mice, the csNox4KO animals failed to display an
increase in Nrf2 target genes upon exercise (Figure 2A), consistent with a lack of Nrf2 activation.
There was no difference between csNox4KO mice and matched control mice in the absence of exer-
cise. The csNox4KO mice achieved a significantly shorter running distance and exercise time than
matched controls during an exercise capacity test (Figure 2B), with the magnitude of defect being
very similar to that observed in global Nox4-null mice. We assessed cardiac contractile function by
echocardiography in conscious mice, immediately upon cessation of the exercise capacity test. While
the left ventricular fractional shortening (FS) increased by 24% in the control group at peak exercise,
there was a 6% decrease in FS in the csNox4KO group (Figure 2C). The increase in FS in control ani-
mals was driven by a decrease in end-systolic dimension, indicative of increased contractility, which
was absent in csNox4KO mice whereas there was no difference in the heart rate response between
groups (Figure 2—figure supplement 1A).
To assess whether the defect in cardiac performance and exercise capacity in csNox4KO mice is
related to the absence of Nrf2 activation, we treated both csNox4KO and control animals with an
Nrf2 activator, sulforaphane, administered for 2 days prior to the exercise capacity test. The treat-
ment with sulforaphane fully restored the exercise-induced increase in cardiac performance and max-
imal exercise capacity in csNox4KO mice (Figure 2, B and C, and Figure 2—figure supplement 1, B
and C). Taken together, these results suggest that cardiomyocyte Nox4-dependent activation of
Nrf2 is essential for the normal physiological increase in cardiac performance during acute exercise,
which is required to achieve maximal exercise capacity.
Cardiomyocyte Nrf2 is required for optimal increments in heart
performance during exercise
To more directly define the role of cardiac Nrf2 in the physiological response to exercise, we gener-
ated a new mouse line with a cardiomyocyte-specific deletion of Nrf2 (csNrf2KO mice, Figure 3, A
and B). The csNrf2KO mice showed a significant cardiac-specific decrease in Nrf2 mRNA levels in
the heart with no change in other organs (Figure 3, C and Figure 3—figure supplement 1B). There
was an approximately 60% reduction in Nrf2 protein in the heart (Figure 3D and Figure 3—figure
supplement 1A), with the residual levels in csNrf2KO mice probably attributable to expression in
non-myocytes. There were no differences in baseline cardiac size or function between csNrf2KO
mice and control Nrf2fl/fl littermates (Figure 3—figure supplement 2). Myocardial levels of Nox4
were similar in csNrf2KO mice and control littermates at baseline and increased to a similar extent in
both genotypes after acute exercise (Figure 3E), confirming that Nox4 lies upstream of Nrf2. How-
ever, when the two groups were subjected to a maximal exercise capacity test, the csNrf2KO mice
Hancock et al. eLife 2018;7:e41044. DOI: https://doi.org/10.7554/eLife.41044 6 of 16
Research article Human Biology and Medicine
exhibited a significant impairment of cardiac function (Figure 3F) and a reduced running distance
and time as compared to control littermates (Figure 4, D and E). These results indicate a critical role
of cardiomyocyte Nrf2 in facilitating an optimal cardiac functional response to acute exercise.
Mitochondrial function is impaired in csNrf2KO mice after exercise
We sought to identify mechanisms that account for the beneficial effects of Nrf2 activation on the
acute response to exercise. Since optimal mitochondrial function is essential to support an increase
in cardiac output during exercise and depends upon a preserved redox state, we investigated mito-
chondrial respiratory function in csNrf2KO mice and control littermates. Cardiac mitochondria were
isolated from csNrf2KO mice and control littermates immediately upon completion of the exercise
capacity test and studied by high-resolution respirometry. There were no significant differences
between sedentary csNrf2KO mice and littermate controls in respiratory capacity measured as ADP-
limited and maximal oxidative phosphorylation (OXPHOSLim and OXPHOSMax, respectively)
(Figure 3G). However, after exercise, both sub-maximal and maximal respiratory capacity were sig-
nificantly lower in csNrf2KO mice compared to littermate sedentary controls (Figure 3G). Neither
mitochondrial efficiency (P:O ratio) nor respiratory coupling ratio (an index of the tightness of cou-
pling between respiration and phosphorylation) were altered by genotype or exercise (Figure 3—
figure supplement 3A and B). Mitochondrial membrane integrity as assessed by the response to
cytochrome C in the oxygraph protocol was similar among groups (Figure 3—figure supplement
3C). Mitochondrial mass, as estimated by the total citrate synthase activity, was also similar between
genotypes (Figure 3H). Results from the substrate-uncoupler-inhibitor-titration (SUIT) protocol con-
firmed impaired mitochondrial oxidative phosphorylation capacity in exercised csNrf2KO hearts
when using fatty acids, complex I and complex I I substrates (Figure 3—figure supplement 3D)
Figure 5. Schematic illustrating the role of the cardiomyocyte Nox4-Nrf2 pathway in enhancing mitochondrial and
cardiac contractile function during acute physiological exercise. Cardiac Nox4 levels increase in response to acute
exercise and induce an activation of Nrf2. The Nrf2-dependent gene program includes endogenous antioxidants
that are critical in maintaining mitochondrial redox balance during peak exercise. The maintenance of
mitochondrial redox balance is essential to achieve maximal mitochondrial respiration and cardiac contractile
function at peak exercise. The sites of action of the Nrf2 activator sulforaphane and the mitochondria-targeted
antioxidant MitoQ are shown.
DOI: https://doi.org/10.7554/eLife.41044.016
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Nox4 and Nrf2 are required for exercise-induced increases in
mitochondrial antioxidants
In view of the impaired mitochondrial function at peak exercise in csNrf2KO mice, we hypothesised
that there may be a defect in the redox homeostasis required for normal respiratory function
(Holmstro¨m et al., 2016). We found that acute exercise resulted in significant increases in the levels
of the major mitochondrial antioxidants peroxiredoxin III (PRXIII), thioredoxin reductase-2 (TRXR2)
and superoxide dismutase 2 (SOD2) in littermate control mouse hearts (Figure 4A and Figure 4—
figure supplement 1). These increases were, however, abolished in the hearts of exercised
csNrf2KO mice although there were no differences between sedentary csNrf2KO and control mice.
A similar abolition of exercise-induced increase in these mitochondrial antioxidants was also found in
Nox4KO hearts (Figure 4—figure supplement 2). These findings indicate that the Nox4/Nrf2 axis is
required for exercise-induced increases in mitochondrial antioxidants.
To investigate the impact of the altered mitochondrial antioxidants in csNrf2KO mouse hearts
with exercise, we assessed mitochondrial hydrogen peroxide (H2O2) levels in vivo using injection of
the mitochondrial-targeted probe MitoB (Cocheme´ et al., 2012). This probe is rapidly concentrated
in mitochondria where it reacts with H2O2 to form MitoP; quantification of the MitoP/MitoB ratio by
LC-MS provides a sensitive measure of mitochondrial H2O2 levels (Logan et al., 2014). We found in
normal mouse hearts that mitochondrial H2O2 levels were significantly lower immediately upon ces-
sation of peak exercise than in the non-exercising state (Figure 4B) – consistent with a reduction in
ROS at peak exercise due to an enhanced antioxidant state. In marked contrast, there was no
decrease in mitochondrial H2O2 levels with exercise in csNrf2KO mice, in line with the failure to
enhance mitochondrial antioxidants. There were no significant differences between genotypes in
sedentary mice.
Supplementation with a mitochondria-targeted antioxidant rescues the
physiological cardiac response and exercise capacity in csNrf2KO mice
Finally, to confirm that the defect in mitochondrial redox balance is responsible for the impaired car-
diac performance and exercise capacity in csNrf2KO mice, we performed rescue experiments in
which mice were treated with a small molecule mitochondria-targeted antioxidant, MitoQ, for 2 days
prior to the exercise capacity test (Smith and Murphy, 2010). We found that MitoQ supplementa-
tion markedly improved cardiac performance at peak exercise in csNrf2KO mice and fully restored
the maximal exercise capacity in these animals (Figure 4, C to E, and Figure 4—figure supplement
3). MitoQ did not have a significant additional effect on exercise performance in control mice.
Discussion
The multiple beneficial effects of regular exercise depend upon the ability of the healthy heart to
safely and consistently increase its contractile performance during the periods when cardiac output
and overall body oxygen consumption are elevated. It has long been recognized that adaptations
that facilitate the heart’s ability to safely undertake repetitive exercise begin to be triggered very
rapidly, after just 1–3 episodes of consecutive exercise. One of the most important of such adapta-
tions may be the maintenance of a physiological redox balance, given that this is crucial for mito-
chondrial energy metabolism and heart contractile performance (Powers et al., 2014). In this study,
we identify cardiomyocyte Nox4 as the physiological driver of exercise-induced upregulation of
endogenous antioxidants, serving to preserve mitochondrial redox state and respiratory function
and thereby facilitate optimal cardiac contractile performance and exercise capacity (Figure 5). We
show that consecutive episodes of exercise upregulate myocardial Nox4 levels and lead to the acti-
vation of an Nrf2-dependent transcriptional program that boosts endogenous antioxidants and miti-
gates oxidative stress during exercise. The cardiomyocyte-specific loss of either Nox4 or Nrf2 results
in a significant reduction in exercise cardiac performance and maximal exercise capacity in healthy
adult mice. The exercise defect in cardiomyocyte-specific Nox4-deficient mice is corrected by a small
molecule Nrf2 activator, sulforaphane, placing Nrf2 activation downstream of Nox4. On the other
hand, the defect in exercise capacity in cardiomyocyte-specific Nrf2-deficient mice can be rescued
by a mitochondria-targeted antioxidant, MitoQ, confirming that it relates to a disruption of
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mitochondrial redox balance. Taken together, these data identify a crucial Nox4-dependent physio-
logical pathway that mediates cardiac adaptation to repeated acute exercise.
The activity of Nox4 depends on its protein abundance but its levels in the healthy adult heart are
very low (Brewer et al., 2011). Previous studies show that an increase in Nox4 abundance is induced
by diverse pathological stresses such as hypoxia, ischaemia and haemodynamic overload
(Zhang et al., 2010). In the current study, cardiac Nox4 mRNA and protein levels were significantly
increased after two bouts of moderate intensity exercise on consecutive days. The precise stimulus
for the increase in Nox4 levels with exercise was not studied. However, the transcriptional induction
of Nox4 by ATF4 was recently identified as an important mechanism for its stress-induced upregula-
tion (Santos et al., 2016), and it is of interest that exercise is reported to upregulate ATF4 in human
skeletal muscle (Drummond et al., 2011). An increase in levels of Nox4 as a ROS-producing protein
complex might be envisaged to generate detrimental oxidative stress. However, it has been found
that Nox4 mediates protective effects in pathological stress situations, such as chronic hemodynamic
overload or nutrient starvation in the heart (Zhang et al., 2010; Sciarretta et al., 2013) and angio-
tensin II-induced remodelling or atherosclerosis in the vasculature (Craige et al., 2015;
Schro¨der et al., 2012; Schu¨rmann et al., 2015). These effects typically involve localized redox sig-
nalling without overt oxidative stress. In fact, Nox4 was found to specifically activate Nrf2 during
load-induced cardiac remodeling (Smyrnias et al., 2015) and during angiotensin II-induced vascular
remodeling (Schro¨der et al., 2012). Here, we show that myocardial Nox4 mediates a similar activa-
tion of Nrf2 during acute exercise – representing to the best of our knowledge the first physiological
function of cardiac Nox4 that has so far been identified. The Nox4-dependent activation of Nrf2 was
required for optimal cardiac function and running capacity during maximal exercise, as evidenced by
the restoration of normal exercise responses in Nox4-deficient animals that were treated with the
Nrf2 activator, sulforaphane. Notably, we observed no increase in cardiac contractility as assessed
by fractional shortening in Nox4-deficient mice at peak exercise whereas there was a 24% increase
in wild-type animals.
Nrf2 is a master transcriptional regulator of antioxidant and stress-defense proteins and previous
studies found that it is activated in the heart upon acute exercise (Muthusamy et al., 2012). A
canonical mechanism for Nrf2 activation is in response to redox signals which result in its post-trans-
lational stabilisation. In principle, Nrf2 activation could be activated by diverse sources of ROS, such
as mitochondria or different Nox isoforms. However, here we find that endogenous Nox4 is an
essential and indispensable regulator of myocardial Nrf2 activation during physiological acute exer-
cise. As such, the acute increase in myocardial Nrf2 protein levels and its major downstream targets
(such as antioxidants and GSH-generating enzymes) was markedly inhibited in the hearts of Nox4-
null mice or csNox4KO mice. Furthermore, this was accompanied by a significant redox imbalance
as assessed by the GSH/GSSG ratio and by evidence of oxidative stress as assessed by the levels of
4-HNE adducts, along with a reduced maximal exercise capacity. Therefore, the absence of Nox4
resulted in redox imbalance during exercise as a result of impaired Nrf2 activation and impaired anti-
oxidant reserve, and led to a significant impairment of exercise performance. The increased ROS lev-
els in this setting most likely emanated from mitochondria (Radak et al., 2013; Saborido et al.,
2011), as evidenced by experiments using the mitochondria-targeted redox probe MitoB and the
mitochondrial-targeted antioxidant MitoQ.
To more specifically establish the role of cardiomyocyte Nrf2 in exercise-induced cardiac adapta-
tion and determine how it enhances exercise performance, we developed a new mouse model with
cardiomyocyte-specific deficiency of Nrf2. These animals had a normal heart structure and function
at baseline but displayed a significant impairment of cardiac performance and running capacity upon
maximal exercise, similar to the phenotype observed in Nox4-deficient animals. The csNrf2KO mice,
however, developed a similar elevation in cardiac Nox4 levels upon exercise to that observed in con-
trol mice, consistent with Nox4 being upstream of Nrf2. Investigation of cardiac mitochondrial func-
tion in csNrf2KO mice revealed that the respiratory capacity at maximal exercise was significantly
impaired compared to control animals, without any differences in mitochondrial mass or membrane
integrity. Although emerging data suggest that Nrf2 can have multi-faceted effects on mitochondrial
metabolism (Dinkova-Kostova and Abramov, 2015; Holmstro¨m et al., 2016; Merry and Ristow,
2016b), we found no difference in cardiac mitochondrial function between sedentary csNrf2KO and
control mice, indicating that the difference between genotypes was specific to exercise. Further
analyses revealed that the csNrf2KO mouse hearts failed to increase the mitochondrial antioxidants
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PRXIII, TRXR2 and SOD2 upon exercise, in contrast to control animals. In parallel, we found that
mitochondrial ROS levels were lower after exercise in control mice (consistent with increased antioxi-
dant levels) but that this response was absent in csNrf2KO mouse hearts. Taken together, these
results indicate that an Nrf2-dependent induction of mitochondrial antioxidants is critical to maintain
redox balance during acute exercise. Our study also shows that cardiomyocyte Nox4 is the essential
activator of this adaptive response, resulting in the maintenance of optimal mitochondrial respiration
and cardiac function during maximal exercise (Figure 5).
Whether antioxidant supplementation improves exercise performance is a controversial question
(Merry and Ristow, 2016a; Ristow et al., 2009). A reduction in excessive oxidative stress resulting
from mitochondrial ROS production is likely to be beneficial but if ROS-mediated adaptive responses
are inhibited by antioxidants, this might be detrimental (Lauer et al., 2005; Sachdev and Davies,
2008). Previous studies have identified several ROS-mediated adaptive responses during exercise.
The current study suggests that what is ultimately most important is the redox balance during exer-
cise, especially at the level of the mitochondria. Targeted antioxidants such as MitoQ that primarily
reduce mitochondrial ROS levels (Oyewole and Birch-Machin, 2015) may be more likely to have
beneficial effects than non-specific antioxidants that might inhibit Nrf2 activation. Interestingly, we
did not find any beneficial effects of either sulforaphane or MitoQ in the control animal groups, sug-
gesting that there is limited scope for further enhancement of the adaptive exercise redox response
in healthy adult mice with normal Nox4/Nrf2 activation, at least in the relatively acute setting. This is
consistent with prior findings that MitoQ did not enhance aerobic training adaptations or skeletal
muscle oxidative capacity in young healthy men (Shill et al., 2016). However, it is possible that the
Nox4/Nrf2/mitochondrial antioxidant pathway could be usefully augmented in older individuals or
those with disease-related impairment of this response.
Taken together, these data identify cardiomyocyte Nox4 as a crucial physiological mediator of
Nrf2 activation, triggering an adaptive response that maintains redox state, mitochondrial function
and cardiac contractile performance to support normal physical exercise.
Materials and methods
Key resources table
Reagent type
(species) or
resource Designation
Source or
reference Identifiers Additional information
Genetic
reagent
(M. musculus)
Nox4-null PMID: 20921387 Dr. Schro¨der (Institut fu¨r
Kardiovaskula¨re Physiologien,
Goethe-Universita¨t)
Genetic
reagent
(M. musculus)
cardiomyocyte-specific
Nox4 knockout
PMID: 29040462 Dr. Shah (King’s College London
British Heart Foundation
Centre of Excellence)
Genetic
reagent
(M. musculus)
Nrf2fl/fl in this paper Dr. Shah (King’s College London
British Heart Foundation
Centre of Excellence)
Genetic
reagent
(M. musculus)
Myl2tm1(cre)Krc The Jackson
Laboratory
(Stock No: 029465)
RRID:IMSR_JAX:029465
Antibody Anti-GSTA2
(rabbit polyclonal)
Sigma-Aldrich
Cat# SAB1401163
RRID:AB_10609834
Antibody Mouse Anti-GAPDH
Monoclonal Antibody
Sigma-Aldrich
Cat# G8795
RRID:AB_1078991
Antibody Anti-4 Hydroxynonenal
Rabbit Polyclonal
Antibody
Abcam Cat# ab46545 RRID:AB_722490
Antibody Anti-MnSOD Rabbit
Polyclonal Antibody
Abcam Cat# ab13533 RRID:AB_300434
Antibody Anti-GCLC Rabbit
Polyclonal Antibody
Novus Cat# NBP1-49762 RRID:AB_10011848
Continued on next page
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Continued
Reagent type
(species) or
resource Designation
Source or
reference Identifiers Additional information
Antibody Anti-Catalase Rabbit
Polyclonal Antibody
Millipore Cat#219010 RRID:AB_211660
Antibody TrxR2 Goat
Polyclonal Antibody
Santa Cruz Biotechnology
Cat# sc-46278
RRID:AB_2210408
Antibody PRX III (C-14) Goat
Polyclonal Antibody
Santa Cruz Biotechnology
Cat# sc-23973
RRID:AB_2237431
Antibody NFE2L2-Rabbit
Polyclonal Antibody
Santa Cruz Biotechnology
Cat# sc-13032
RRID:AB_2263168
Antibody NFE2L2-Rabbit
Polyclonal Antibody
Santa Cruz Biotechnology
Cat# sc-722,
RRID:AB_2108502
Antibody VE-cadherin (F-8)
monoclonal antibody
Santa Cruz Biotechnology
Cat# sc-9989
RRID:AB_2077957
Antibody Anti-p47-phox (mouse)
antibody
Millipore Cat# 07–500 RRID:AB_310668
Antibody gp91phox mouse
monoclonal antibody
BD Biosciences
Cat# 611414
RRID:AB_398936
Antibody Nox4 rabbit polyclonal
antibody
PMID: 18467643 Anilkumar et al. (2008)
Animals
The studies complied with the UK Home Office Guidance on the Operation of the Animals (Scientific
Procedures) Act, 1986 and King’s College London institutional guidelines. All the mouse lines stud-
ied were on a C57BL/6 background. Global Nox4KO mice were described previously (Zhang et al.,
2010) and were compared to littermate wild-type controls. Inducible cardiomyocyte-specific
Nox4KO mice (csNox4KO) were generated by crossing Nox4fl/fl female mice with male a-MHC-Mer-
CreMer mice (Zhang et al., 2018). Tamoxifen was administered by i.p. injection (20 mg/kg/day) for
5 days to induce Cre expression. csNox4KO mice were compared with tamoxifen-treated Cre-nega-
tive Flox littermates, with the groups subjected to the exercise regime 1 week after completion of
tamoxifen treatment. Tamoxifen treatment itself had no effect on cardiac function (data not shown).
The generation of Nrf2fl/fl mice was commissioned from Taconic-Artemis (Germany). In brief, the
targeting vector was generated using BAC clones from the C57BL/6 RPCI-23 BAC library. The LoxP
sites flanked exons 2 and 5 and the vector included an FRT (neomycin resistance) and F3 (puromycin
resistance) site. The targeting vector was transfected into C57BL/6 Tac embryonic stem (ES) cell lines
and recombinant clones were identified by PCR and Southern blotting, then injected into blasto-
cysts. Heterozygous Floxed mice obtained from germline chimeras were bred with C57BL/6 Flp-
deletor mice to excise the resistance cassettes. Mice were backcrossed onto a C57BL/6 background.
Cardiomyocyte-specific Nrf2 knock-out mice (designated as csNrf2KO) were obtained by crossing
Nrf2fl/fl mice with Cre-recombinase expressing mice under the control of a cardiomyocyte-specific
Mlc2v promoter (Mlc2vCre). csNrf2KO and littermate Nrf2fl/fl controls were obtained by intercrossing
Mlc2vCre+/-/Nrf2fl/fl mice with Nrf2fl/fl mice.
Acute exercise regimes
We studied female Nox4-null mice, csNox4KO mice or csNrf2KO mice and their respective litter-
mate controls. Mice of age approximately 8 weeks were acclimatized to and trained on a 12.5˚ uphill
Exer 3/6 open treadmill (Columbus Instruments) for 2 days. On both training days, mice ran for a
total of 10 min, with a continual increase in speed up to a final speed of 15 m/min. Mice were then
randomly assigned into a sedentary or exercise group. The exercise regime used in the study is a
moderate intensity protocol as reported previously (Hafstad et al., 2011; Muthusamy et al., 2012).
Briefly, on day 3 and 4 (experimental days 1 and 2), mice in the exercise group were subjected to a
single bout of running at 15 m/min at a gradient of 12.5˚ for a total of 1500 m. Tissues for analyses
of gene expression or immunoblotting were obtained after the second prolonged period of
exercise.
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Exercise capacity tests were performed on day 5 (experimental day 3). Mice started running at an
initial treadmill speed of 15 m/min for 30 min. The speed was then increased at 1 m/min every 10
min for another 30 min, followed by a 1 m/min increase every 5 min until the mice were exhausted.
Exhaustion was defined as the point at which mice spent more than 5 s on the electric shocker with-
out attempting to resume running. The total running distance and running time were calculated for
each mouse (He et al., 2012). In some experiments, sulforaphane (0.5 mg/kg i.p.) or MitoQ (4 mg/
kg i.p.) were administered 24 hr and 2 hr prior to each exercise regime, respectively.
Echocardiography
Immediately upon discontinuation of the exercise capacity test, cardiac function was evaluated in
conscious mice by transthoracic echocardiography using a Vevo2100 system (Visualsonics, Canada)
(Zhang et al., 2015). Echocardiography was undertaken on the same mouse prior to exercise as a
baseline. Echocardiography was performed by an experienced operator blinded to the assignments.
Images were acquired using M-mode at a depth setting of 11 mm and analyzed using Vevo software
v1.7. Mice were acclimatized to conscious echocardiography over 2–3 days. Basal cardiac structure
and function in sedentary csNrf2KO mice was assessed by echocardiography under 2% isoflurane
anesthesia at heart rates > 400 bpm (Zhang et al., 2015).
Real-time PCR
mRNA expression levels were quantified by real-time RT-PCR using SYBR Green on an Applied Bio-
system PRISM 7700 machine. Delta delta Ct values were calculated with hypoxanthine-guanine phos-
phoribosyltransferase (HPRT) as an internal control. Primer sequences were (forward, reverse):
Nfe2l2, Nuclear factor, erythroid 2 like 2 (or Nrf2): CTACTCCCAGGTTGCCCACA, CGACTCA
TGGTCATCTACAAATGG;
Nox4, NADPH oxidase-4: CCGGACAGTCCTGGCTTATC, TGCTTTTATCCAACAATCTTCTTTT;
Cat, Catalase: CCCTTCGCAGCCATGTG, GCTGAGAAGCCTAAGAACGCAAT;
Gsta2, Glutathione S-transferase, alpha 2 (Yc2): GCTTGATGCCAGCCTTCTG, GGCTGCTGATTC
TGCTCTTGA;
Gclc, Glutamate-cysteine ligase, catalytic subunit: GTTATGGCTTTGAGTGCTGCAT, ATCAC
TCCCCAGCGACAATC;
Txnrd1, thioredoxin reductase 1: GATGCACCAGGCAGCTTTG; TCTTCGACTTTCCAGCCATAGT;
Hprt, Hypoxanthine guanine phosphoribosyl transferase: CACAGGACTAGAACACCTGC, GC
TGGTGAAAAGGACCTCT;
Western blotting
Snap-frozen heart tissues were homogenized for immunoblotting. Antibodies used were: Nrf2, thio-
redoxin reductase-2, peroxiredoxin III and cadherin (Santa Cruz); Nox4 (Anilkumar et al., 2008);
Nox2 (BD Biosciences); p47phox, catalase (Millipore); glutathione S-transferase A2, 4-hydroxynonenal,
superoxide dismutase-2 (Abcam); glutamate-cysteine ligase catalytic subunit (Novus biologicals).
GAPDH (Sigma) was used as a loading control. Protein bands were visualized using enhanced chemi-
luminescence or fluorescence (Odyssey, LI-COR), and were quantified by densitometry.
Membrane proteins were obtained from heart homogenates using a standard centrifugation pro-
tocol (Lu et al., 2009). Cadherin and GAPDH were used as protein markers for the membrane and
cytosolic fractions, respectively.
Glutathione assay
The ratio of glutathione/glutathione disulfide (GSH/GSSG) in left ventricular homogenates was evalu-
ated using a GSH-Glo assay kit (Promega) (Brewer et al., 2011), as a global measure of antioxidant
status in the heart.
Estimation of mitochondrial H2O2in vivo
The mitochondrial-targeted probe, MitoB, was used to assess mitochondrial H2O2 levels in vivo, as
previously described (Cocheme´ et al., 2012; Logan et al., 2014). MitoB can also react with peroxy-
nitrite, but this reactive nitrogen species was not thought to contribute to the changes seen here.
Briefly, 25 nmol MitoB in 50 mL saline was administered by tail vein injection 2 hr before the exercise
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capacity test on experimental day 3. Hearts were excised immediately upon completion of exercise,
snap frozen in liquid nitrogen and stored at  80˚C. For analysis, around 50 mg tissue was homoge-
nized and spiked with deuterated internal standards. MitoB and MitoP (produced by the reaction
with H2O2) were extracted and quantified by liquid chromatography-tandem mass spectrometry rel-
ative to a standard curve (Cocheme´ et al., 2012; Logan et al., 2014).
Mitochondrial respiratory function
Cardiac mitochondria were isolated immediately upon completion of the exercise capacity test and
respiratory function was measured in an oxygraph (Oxygraph 2 k; Oroboros Instruments, Austria) as
described previously (Hafstad et al., 2013; Nabeebaccus et al., 2017). Briefly, proton leak (Leak)
respiration was measured with pyruvate (5 mM) and malate (1 mM) as substrates. ADP-limited respi-
ration (oxidative phosphorylation, OXPHOSLim) was measured in the presence of ADP, 50 mM. Maxi-
mal mitochondrial respiratory capacity (OXPHOSMax) was measured following the addition of ADP,
500 mM. Cytochrome C (10 mM) was added to assess mitochondrial membrane integrity (OXPHO-
SCyt). All respiration rates were normalized by the protein content. The phosphate/oxygen ratio (P/O
ratio) was calculated from the ratio of molecules phosphorylated to each oxygen molecule con-
sumed. Respiratory coupling ratio (RCR) was calculated as OXPHOSMax/Leak.
In order to further study the mitochondrial function, a substrate-uncoupler-inhibitor-titration
(SUIT) protocol was performed. Proton leak (LeakFA) was measured in the presence of malate (0.5
mM), carnitine (5 mM) and palmityol-CoA (24 mM). Maximal respiratory capacity (oxidative phosphor-
ylation, OXPHOS) was measured following the addition of a saturating amount of ADP (500 mM,
OXPHOSFA), saturating amounts of the complex I substrates pyruvate (10 mM) and glutamate (10
mM, OXPHOSFA+CI) and the complex I I substrate succinate (10 mM, OXPHOSFA+CI+CII). Maximal
electron transport capacity (ETC) was measured following the addition of 0.75 mM carbonyl cyanide
m-chlorophenyl hydrazone (CCCP) (ETCFA+CI+CII). Rotenone (0.5 mM) was used to inhibit complex I
(ETCCII) and complex I I and III were inhibited by malonic acid (5 mM) and antimycin (2.5 mM),
respectively (Residual oxygen consumption, ROX). The absolute ROX value was subtracted from the
values of measured respiration.
Statistics
Data are presented as mean ± SEM. Comparisons were made by unpaired t-test, 1-way or 2-way
ANOVA as appropriate, followed by Tukey post hoc analysis. p<0.05 was considered significant.
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